Central sympatho-inhibitory effects of intracisternal and intravenous administrations of noradrenaline in high doses.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D002946:Cisterna Magna; D003714:Denervation; D004147:Dioxins / Q000494:pharmacology; D004558:Electric Stimulation; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D007267:Injections; D007275:Injections, Intravenous; D008297:Male; D009475:Neurons, Afferent / Q000502:physiology; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology; D012584:Sciatic Nerve / Q000502:physiology; D013153:Splanchnic Nerves / Q000187:drug effects / Q000502:physiology; D013564:Sympathetic Nervous System / Q000187:drug effects*; D013997:Time Factors; D014043:Tolazoline / Q000494:pharmacology; D015016:Yohimbine / Q000494:pharmacology
D004147:Dioxins; D010880:Piperidines; D015016:Yohimbine; D014043:Tolazoline; D009638:Norepinephrine